Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by topic
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by topic
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 8, Issue 1
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Basic tumor immunology
Original research
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer
Online download statistics by month:
Online download statistics by month: April 2020 to May 2021
Abstract
Full
Pdf
Apr 2020
263
263
201
May 2020
218
218
78
Jun 2020
108
108
39
Jul 2020
76
76
27
Aug 2020
56
57
24
Sep 2020
68
68
33
Oct 2020
73
73
35
Nov 2020
74
74
23
Dec 2020
73
73
103
Jan 2021
85
85
21
Feb 2021
75
75
36
Mar 2021
117
117
42
Apr 2021
83
83
37
May 2021
85
85
30
Total
1454
1455
729
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF